LRE Medical Announces Appointment of New Chief Executive Officer
Munich, Germany – LRE Medical, a leading CDMO providing advanced diagnostic and life-science solutions, is pleased to announce the appointment of Dr. Klaus Lun as its new Chief Executive Officer, effective November 1, 2024. This strategic appointment is backed by Gyrus Capital, a prominent private equity firm specializing in transformational investments in healthcare and sustainability sectors.
Dr. Lun brings over 20 years of experience in the life sciences, biotech, and diagnostics industries, with a proven track record of driving growth, innovation, and value creation. His extensive background includes key leadership roles at Tecan, Danaher Corporation, and Lonza Group. At Tecan, Dr. Lun served as the Executive Vice President of the Life Science Business and Member of the Management Board, where he was responsible for full P&L oversight and led the division to achieve significant growth. He was instrumental in deploying strategies for both organic and inorganic growth, resulting in double-digit revenue increases and substantial bottom-line expansion. His tenure at Danaher saw him take on vital roles in global product marketing, strategy, and business development, where he redefined growth strategies and spearheaded new product developments.
Dr. Lun holds a PhD in Neurobiology from the University of Heidelberg, an MA in Business Administration from the University of Mannheim, and an MA in Human Genetics from the University of Tübingen. He has been recognized for his achievements in strategic development and business growth throughout his career.
"We are thrilled to welcome Dr. Klaus Lun to LRE Medical," said Dr. Henrik Schimmell, Chair of LRE Medical. "His vision, experience, and leadership skills are exactly what we need to guide our company through its next phase of growth and success."
Dr. Lun expressed enthusiasm about joining LRE Medical, stating, "I am honored to lead such a dynamic and innovative organization. With the support of Gyrus Capital, we are well-positioned to advance our mission of delivering cutting-edge diagnostic solutions that enhance patient care and support healthcare professionals globally."
Dr. Robert Watson, Managing Partner at Gyrus Capital, added, "We are excited to welcome Klaus Lun to LRE Medical. His impressive background and visionary leadership will be invaluable as we continue to grow and innovate. We are confident that Klaus will steer LRE Medical to new heights and create significant value for all stakeholders."
For more information, please visit LRE Medical Website (www.lre.de)
About LRE Medical
LRE Medical, a leading CDMO providing advanced diagnostic and life-science solutions, is renowned for its high-quality engineering and manufacturing of diagnostic devices. With over 60 years of experience, LRE Medical specializes in developing innovative solutions for point-of-care diagnostics, laboratory automation, and life sciences. The company collaborates closely with its clients to tailor solutions that meet specific diagnostic needs, ensuring high performance and reliability. LRE Medical’s commitment to quality and innovation has established it as a trusted partner in the global diagnostics market.
About Gyrus Capital
Gyrus Capital is a European investment firm dedicated to transformational investments in the healthcare and sustainability sectors. Based in Geneva, Switzerland, Gyrus invests in businesses that address structural needs of society and the environment, and that are positioned for long-term, sustainable growth. Gyrus has a focus on complex transactions, with particular focus on corporate carve outs and entrepreneur successions in the €50 million to €500 million range. A renowned group of experienced operating partners and industry experts support Gyrus in its active investment and value-creation approach in close partnership with entrepreneurs and managers.
To learn more, please visit www.gyruscapital.com